The Week Ahead In Biotech: Johnson & Johnson Kickstarts Big Pharma Earnings

Last week was a quiet one for the biotech space with the exception of a few clinical trial readouts.

Pharma and biotech stocks took comfort in a ruling by a federal judge that went against President Donald Trump's initiative that would require drug companies to reveal the sticker price of their drugs in TV ads.

The following are some key catalysts for the biotech stocks in the unfolding week.